Literature DB >> 5957168

Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.

T S Danowski, J F Novak, R W Saul, J W Vester, C Moses.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5957168     DOI： 10.1002/cpt196675631

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

1.  Effect of clofibrate on glucose tolerance in maturity onset diabetes.

Authors:  D Barnett; J G Craig; D S Robinson; M P Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

Authors:  G G Duncan; F A Elliott; T G Duncan; J Schatanoff
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

3.  Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

Authors:  J C Daubresse; D Daigneux; M Bruwier; A Luyckx; P J Lefebvre
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.